The Delhi High Court ordered the Centre and state government to report on the availability of Antihemophilic Factor (AHF) injections for hemophilia treatment, emphasizing the need for an uninterrupted supply. The next hearing is set for December 12, seeking updates on the supply chain for affected hospitals.
